SOURCE: Xtalks

Xtalks Webinars

April 04, 2016 06:30 ET

Tufts Report & Removing the Blinders in Site Selection, New Webinar Hosted by Xtalks

TORONTO, ON --(Marketwired - April 04, 2016) - During a live broadcast on Tuesday, April 26, 2016, Ken Getz, Director of Sponsored Research Programs & Associate Professor at Tufts Center for the Study of Drug Development, will discuss the findings of a new study assessing practices and inefficiencies associated with site selection, study startup, and site activation in starting clinical trials.

Poorly performing sites have long been a challenge for the industry. Research indicates that half of investigative sites under-enroll with 11% of sites in a multi-center study failing to recruit a single patient. Over 80% of clinical trials fail to meet their original timelines, with poor site selection increasing cost of trials by 20% or more. The downstream cost ramifications are significant with a typical Phase III study incurring $2.25 million in expenses for non-active and under-enrolling sites.

Sponsors are under increasing pressure to choose the 'right' sites at the same time that competition is intensifying and recruitment rates are falling. The current practice of adding more sites per study and requiring each sight to recruit fewer subjects per site is a questionable risk mitigation approach.

Judy Luk-Smit, Director of Product Management at goBalto, will introduce Select, a purpose-built study startup (SSU) site selection and feasibility tool that can improve site selection capability by combining internal and external data sources so a complete target site profile can be created. Select mitigates risk factors for recruitment and retention by finding the optimum alignment of top-performing sites with substantial patient databases, and quickly assessing which sites have performed best in similar studies. As part of this effort, Select provides information on start-up time, patient retention and quality. It can also facilitate communications and a desire to build a collaborative long lasting partnership, fostering a foundation of trust and commitment.

To learn more about this event visit: Tufts Report & Removing the Blinders in Site Selection

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit

For information about hosting a webinar visit

Image Available:

Contact Information